Antibody Response to ChAdOx1-nCoV-19 Vaccine Among Recipients in Bangladesh: A Prospective Observational Study

Antibody Response to ChAdOx1-nCoV-19 Vaccine Among Recipients in Bangladesh: A Prospective Observational Study

Ashraful Hoque,1 Anindita Das Barshan,2 Forhad Uddin Hasan Chowdhury,2 Jannatul Fardous,3 Mohammad Jahid Hasan,3 Md Abdullah Saeed Khan,3 Ahmedul Kabir4 1Department of Blood Transfusion, Sheikh Hasina National Institute of Burn and Plastic Surgery, Dhaka, Bangladesh; 2Department of Medicine, Dhaka M...

Full description

Bibliographic Details
Main Authors:	Hoque A, Barshan AD, Chowdhury FUH, Fardous J, Hasan MJ, Khan MAS, Kabir A
Format:	Article
Language:	English
Published:	Dove Medical Press 2021-12-01
Series:	Infection and Drug Resistance
Subjects:	chadox1-ncov vaccine covid-19 bangladesh antibody response
Online Access:	https://www.dovepress.com/antibody-response-to-chadox1-ncov-19-vaccine-among-recipients-in-bangl-peer-reviewed-fulltext-article-IDR

Similar Items

An autopsy case of cerebral arterial thrombosis after vaccination with ChAdOx1 nCOV-19
by: Hyeji Yang, et al.
Published: (2022-08-01)

Effectiveness of the chAdOx1 nCoV-19 vaccine in preventing COVID-19 infection
by: Tarana Sarwat, et al.
Published: (2022-01-01)

AZD1222 (ChAdOx1 nCoV-19) Vaccine: Hurdles and Visions
by: Md. Altamash Ahmad, et al.
Published: (2023-03-01)

Humoral Immunogenicity and Reactogenicity of the Standard ChAdOx1 nCoV-19 Vaccination in Taiwan
by: Jer-Hwa Chang, et al.
Published: (2022-02-01)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
by: Tamara Garibashvili, et al.
Published: (2022-06-01)

The immunogenicity of the ChAdOx1 nCoV-19 vaccination in participants with underlying comorbidity diseases: A prospective cohort study
by: Thachanun Porntharukchareon, et al.
Published: (2023-08-01)

A Review on Suggested Mechanisms in Thrombocytopenia and Thrombosis Following ChAdOx1 nCoV-19 Vaccination
by: Negar Mottaghi Dastgerdi, et al.
Published: (2021-11-01)

Remitting seronegative symmetrical synovitis with pitting oedema following administration of the ChAdOx1-S/nCoV-19 Coronavirus vaccine
by: Syed Aun Muhammad, et al.
Published: (2023-06-01)

Immunogenicity Differences of the ChAdOx1 nCoV-19 Vaccine According to Pre-Existing Adenovirus Immunity
by: Jinnam Kim, et al.
Published: (2023-04-01)

Covid Antibody Titers in Cancer Patients Following Vaccination with ChAdOx1 nCOV-19 Vaccine
by: Ashish Chavan, et al.

Fatal myositis, rhabdomyolysis and compartment syndrome after ChAdOx1 nCoV-19 vaccination
by: Szu-Ting Huang, et al.
Published: (2022-12-01)

Severe but Self-Limiting Polyarthralgia with Functional Impairment Following ChAdOx1 nCov-19 Vaccination in an Elderly Recipient
by: Joel Ern Zher Chan, et al.
Published: (2021-10-01)

Minimal change disease (MCD) following vaccination with ChAdOx1 nCoV-19 vaccine in a young Indian male: A case report
by: Amresh Krishna, et al.
Published: (2022-01-01)

Comparative effectiveness of BNT162b2 and ChAdOx1 nCoV-19 vaccines against COVID-19
by: Jie Wei, et al.
Published: (2023-02-01)

Case report: Early onset Marin-Amat syndrome after receiving ChAdOx1 nCoV-19 vaccination
by: Ping-Feng Tsai, et al.
Published: (2022-11-01)

Case Report: Hypergranular Platelets in Vaccine-Induced Thrombotic Thrombocytopenia After ChAdOx1 nCov-19 Vaccination
by: Shane P. Comer, et al.
Published: (2022-02-01)

An Immunobridging Study to Evaluate the Neutralizing Antibody Titer in Adults Immunized with Two Doses of Either ChAdOx1-nCov-19 (AstraZeneca) or MVC-COV1901
by: Josue Antonio Estrada, et al.
Published: (2022-04-01)

Acute Polyserositis with Cardiac Tamponade and Bilateral Refractory Pleural Effusion after ChAdOx1 nCoV-19 Vaccination
by: Guan-Yi Li, et al.
Published: (2022-08-01)

Risk of Thrombosis Following the First Dose of ChAdOx1 nCoV-19 Vaccine in Patients Undergoing Maintenance Hemodialysis: A Self-Controlled Case Series Study
by: Shao SC, et al.
Published: (2023-09-01)

Digital PCR to quantify ChAdOx1 nCoV-19 copies in blood and tissues
by: Anita Badbaran, et al.
Published: (2021-12-01)

Immunogenicity evaluation of ChAdox1 nCov-19 (AZD1222) vaccine in solid cancer patients in Chulabhorn Hospital
by: Piyarat Limpawittayakul, et al.
Published: (2022-11-01)

ChAdOx1 nCoV-19 Vaccine Side Effects among Healthcare Workers in Trinidad and Tobago
by: Chavin D. Gopaul, et al.
Published: (2022-03-01)

A Quantitative Benefit–Risk Analysis of ChAdOx1 nCoV-19 Vaccine among People under 60 in Italy
by: Raffaele Palladino, et al.
Published: (2021-06-01)

ChAdOx1 nCoV-19 Immunogenicity and Immunological Response Following COVID-19 Infection in Patients Receiving Maintenance Hemodialysis
by: Wisit Prasithsirikul, et al.
Published: (2022-06-01)

Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study
by: Nattaya Teeyapun, et al.
Published: (2022-10-01)

Sequential observation of antibody response pattern at 3 and 6 months following ChAdOx1 nCoV-19 vaccination among health care workers-A prospective single cohort study
by: Ponnu Jose, et al.
Published: (2022-10-01)

Safety of ChAdOx1 nCoV-19 Vaccine: Independent Evidence from Two EU States
by: Abanoub Riad, et al.
Published: (2021-06-01)

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review
by: Homa Faghihi, et al.
Published: (2023-11-01)

Adverse Events Following Immunization Associated with the First and Second Doses of the ChAdOx1 nCoV-19 Vaccine among Healthcare Workers in Korea
by: Minji Jeon, et al.
Published: (2021-09-01)

Study on the adverse events following immunization (AEFI) of ChAdOx1 nCoV-19 vaccine in a group of Sri Lankan medical officers
by: JAMA Jayatilake, et al.
Published: (2022-04-01)

Possible side effects of ChAdOx1 nCov-19 vaccine in patients with sickle cell disease
by: Salam Alkindi, et al.
Published: (2021-09-01)

Comparison of Antibody Persistence up to 6 Months after Additional Booster Vaccination with ChAdOx1 nCoV-19 Vaccine
by: Pawita Suwanwattana, et al.
Published: (2023-06-01)

The Effects of CoronaVac and ChAdOx1 nCoV-19 in Reducing Severe Illness in Thailand: A Retrospective Cohort Study
by: Thanyarat Promlek, et al.
Published: (2023-01-01)

Case Report: Cytomegalovirus Reactivation and Pericarditis Following ChAdOx1 nCoV-19 Vaccination Against SARS-CoV-2
by: Marlene Plüß, et al.
Published: (2022-01-01)

Seropersistence of SII-ChAdOx1 nCoV-19 (COVID-19 vaccine): 6-month follow-up of a randomized, controlled, observer-blind, phase 2/3 immuno-bridging study in Indian adults
by: Prasad S. Kulkarni, et al.
Published: (2024-12-01)

Active surveillance of adverse events following ChAdOx1 nCoV-19 immunization in geriatric population: a prospective multi-centric study from Jaipur, Rajasthan, India
by: Anil Bhandari, et al.
Published: (2022-01-01)

High Prevalence of Anti-PF4 Antibodies Following ChAdOx1 nCov-19 (AZD1222) Vaccination Even in the Absence of Thrombotic Events
by: Evangelos Terpos, et al.
Published: (2021-07-01)

Immunogenicity of The BNT162b2 COVID-19 mRNA and ChAdOx1 nCoV-19 Vaccines in Patients with Hemoglobinopathies
by: Osman O. Radhwi, et al.
Published: (2022-01-01)

Lung Transplant Recipients Immunogenicity after Heterologous ChAdOx1 nCoV-19—BNT162b2 mRNA Vaccination
by: Emilie Catry, et al.
Published: (2022-07-01)

Immunogenicity and reactogenicity of heterologous prime-boost vaccination with inactivated COVID-19 and ChAdOx1 nCoV-19 (AZD1222) vaccines, a quasi-experimental study
by: Kriangkrai Tawinprai, et al.
Published: (2023-01-01)